Preceptis Medical manufactures pediatric surgical technologies designed especially for the unique needs of children and the medical professionals that care for them. The Hummingbird™ TTS (Tympanostomy Tube System) minimizes surgical trauma (pain) during ear tube placement allowing physicians the option to use moderate sedation for routine ear tube procedures.
This important alternative provides an option for less anesthesia in young children, potentially reduces healthcare costs by moving the procedure out of the O.R. – and allows added convenience for families and their children who undergo over 1.2 million ear tube procedures in the U.S., annually.1
Steve Anderson is the CEO of Preceptis Medical, Inc. Prior to this position, he was the President of Acorn Cardiovascular, Inc., a medical device manufacturer developing life-sustaining therapies for the treatment of systolic heart failure. Steve has 30 years of experience in the medical device industry, starting with Medtronic and including senior management positions at St. Jude Medical, TÜV Product Service, St. Croix Medical, and Acorn Cardiovascular. His specific core competencies include development, regulatory, clinical, reimbursement, quality, and compliance.
Steve has a BS in Materials Engineering and an MS in Biomedical Engineering from the University of Minnesota. He was an Adjunct Professor at the University of St. Thomas Graduate School, has served on multiple boards for medical device companies (both public and private), and has authored numerous publications on medical device regulation and reimbursement (both US and worldwide).
Mark has more than 30 years of global experience in the medical device industry. He served most recently as President and CEO of Minnesota-based Celleration, until its acquisition by Alliqua in May 2015. Prior to Celleration, Mark co-founded and served as board chairman for Orasi Medical, a University of Minnesota spinout developing diagnostic tools for neurological diseases. Additionally, he served as President and CEO for both Reshape Medical and ProVation Medical, and as Chairman and CEO of Survivalink. Mark’s experience also includes a number of executive leadership positions at Nellcor Puritan Bennett. He began his career at GE Healthcare where he worked in marketing, business development and finance. In addition to completing executive leadership and corporate training programs, Mark earned a Bachelor of Science in Business Administration from the University of Southern California.
Michael K. Loushin, MD
Founder and Board Member
Dr. Loushin is a board certified anesthesiologist with over 14 years of clinical experience and expertise in medical device and IP development, clinical studies, and perioperative medicine. Dr. Loushin is a partner with Twin Cities Anesthesia Associates, PA and an adjunct in the Department of Anesthesiology, University of Minnesota. Dr. Loushin completed anesthesiology residency at the University of Minnesota, and his clinical practice includes pediatric, cardiac, and general anesthesia. Dr. Loushin has served as medical director of perioperative services at University of Minnesota Medical Center-Fairview and Fairview Maple Grove Surgery Center providing leadership in patient safety, OR efficiency, and LEAN/process improvement.
David S. Overman
Chief Operating Officer for Prime Therapeutics
David S. Overman, was appointed May of 2017, interim Chief Operating Officer for Prime Therapeutics, a pharmacy benefit manager (PBM) serving nearly 26 million people. Prior to this, he served as President and Chief Operating Officer for Children’ Hospital and Clinics of Minnesota for the past 11 years. Responsible for the performance of the Children’s health system, implementing strategic initiatives, delivering cost effective, quality care with exceptional patient family experience. Prior to joining Children’s, Mr. Overman served as vice president of information systems at Express Scripts, a large national company that manages pharmacy benefits. During his 9 years at Express Scripts, he led an information technology staff of more than 800 employees.
Mr. Overman has a Bachelor of Arts Degree in Business administration from Lakeland University and serves on the board of directors for Ronald McDonald House Charities, Preceptis Medical Inc. and Lake Wapogasset Lutheran Bible Camp.
Mr. Geyen brings a 25-years of leadership experience in fast-paced, rapidly growing public and private life science companies. Most recently he served as Chief Financial Officer of NeuWave Medical through the acquisition by Johnson & Johnson. Prior to NeuWave Medical, he served as the Chief Financial Officer of Celleration, a venture-backed company focused on developing and commercializing therapeutic ultrasound healing technologies, through their acquisition by Alliqua BioMedical. Previously, he served as the Chief Financial Officer of Restore Medical, a manufacturer of innovative medical devices to treat sleep-disordered breathing, where he successful completed an initial public offering and the eventual sale of Restore to Medtronic. Mr. Geyen also previously served as Chief Financial Officer of Acorn Medical and Urologix and began his career at Ernst and Young. Mr. Geyen holds a Bachelor’s degree in Business Administration and Accounting from the University of St. Thomas – St. Paul, MN. Mr. Geyen is also a licensed CPA (Inactive).
V.P. Product Design and Development
Keith Leland is the VP of Research and Development of Preceptis Medical. He has 20 years of experience bringing new medical devices to market. Keith graduated from the University of MN with an MS in mechanical engineering, and has experience in development, intellectual property, and operations.
V.P. Marketing and Education
Carla Dahl comes to Preceptis with twenty years strategic marketing and brand strategy leadership in consumer/retail and life-science technologies — from start-ups to large, global companies. Trusted advisor for pre-market through commercialization planning, P&L management, distinctive brand development and cross-channel communications, sales field alignment, KOL development, and global launch strategies.
Former positions held by Carla include: Director of Global Marketing Communications at St. Jude Medical; Advisory Board Co-Chair/Marketing for Life Science Alley; Director of Marketing at Cardiovascular Systems (pre-FDA clearance through commercialization for original technology launch, with $47million in sales its first commercial year); and Communications Manager/Consultant at Medtronic in Cardiac Surgery and Neuro divisions. Prior to that, Carla used her advertising agency experience to successfully develop and launch Parentprops, a line of baby accessories marketed to parents, sold at Target Stores. Carla graduated from St. Olaf and the University of Minnesota with a Bachelor’s degree.
V.P. of Sales
Bob Wood brings over 30 years of sales, marketing and senior sales management experience to Preceptis. Bob has served as Chief Commercial Officer for OrbusNeich; VP of Sales then VP of Training and Professional Education at Acclarent; VP of WW Sales and Marketing at Novoste and Regional Sales Manager at Perclose. He held various sales and management positions in his 11 years at Cordis Corporation including National Sales Manager of Cordis Endovascular Systems. Bob began his medical device career in sales at Medrad Corp.
- Range derived from the following sources: American Academy of Otolaryngology (AAO) 2013 1.3M – largest industry association; Thomson Reuters from 2013 of 1.23M plus 200K in adults; Millennium Research Group 2013 1.4M (MRG data for private payers: hospitals and ASCs)